The United Kingdom is seeing a growing interest in copyright substances , particularly N,N-Dimethyltryptamine and this lesser-known cannabinoid. Researchers are increasingly studying the potential of these chemicals for mental health purposes, resulting in a nuanced dialogue around their regulato